For at-risk outpatient Medicare beneficiaries, individual MIPS eligible clinicians and groups must attest to implementation of systematic preventive approaches in clinical practice for at least 60 percent for the 2018 performance period and 75 percent in future years, of electronic medical records with documentation of screening patients for abnormal blood glucose according to current US Preventive Services Task Force USPSTF) and/or American Diabetes Association (ADA) guidelines.
Evidence supporting implementation of systematic preventive approaches in clinical practice for abnormal blood glucose
1) Total stratified number of Medicare patients at risk for abnormal blood glucose; and
2) Percentage of each demographic group and the total screened for abnormal blood glucose as outlined by the US Preventive Services Task Force USPSTF) and/or American Diabetes Association (ADA) guidelines.
Examples of Additional Activities that Qualify for Attestation
Completing these alternate activities can fulfill the requirements of this Improvement Activity; and Notes
Please note: CMS examples of stratification may include, patient demographics such as race/ethnicity, disability status (if available), sexual orientation (if available), sex, gender identity (if available), and geography